255 related articles for article (PubMed ID: 2522751)
1. Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
Erlich KS; Jacobson MA; Koehler JE; Follansbee SE; Drennan DP; Gooze L; Safrin S; Mills J
Ann Intern Med; 1989 May; 110(9):710-3. PubMed ID: 2522751
[TBL] [Abstract][Full Text] [Related]
2. Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
Hardy WD
Am J Med; 1992 Feb; 92(2A):30S-35S. PubMed ID: 1531285
[TBL] [Abstract][Full Text] [Related]
3. Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
MacPhail LA; Greenspan D; Schiødt M; Drennan DP; Mills J
Oral Surg Oral Med Oral Pathol; 1989 Apr; 67(4):427-32. PubMed ID: 2524706
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
Chatis PA; Miller CH; Schrager LE; Crumpacker CS
N Engl J Med; 1989 Feb; 320(5):297-300. PubMed ID: 2536137
[No Abstract] [Full Text] [Related]
5. Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
Stellbrink HJ; Albrecht H; Löning T; Greten H
Klin Wochenschr; 1991 Apr; 69(6):274-8. PubMed ID: 1828096
[TBL] [Abstract][Full Text] [Related]
6. A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
Safrin S; Crumpacker C; Chatis P; Davis R; Hafner R; Rush J; Kessler HA; Landry B; Mills J
N Engl J Med; 1991 Aug; 325(8):551-5. PubMed ID: 1649971
[TBL] [Abstract][Full Text] [Related]
7. Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
Safrin S; Assaykeen T; Follansbee S; Mills J
J Infect Dis; 1990 Jun; 161(6):1078-84. PubMed ID: 2161035
[TBL] [Abstract][Full Text] [Related]
8. Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS.
Marks GL; Nolan PE; Erlich KS; Ellis MN
Rev Infect Dis; 1989; 11(3):474-6. PubMed ID: 2546244
[TBL] [Abstract][Full Text] [Related]
9. Foscarnet effective in acyclovir-resistant herpes.
Am Pharm; 1991 Nov; NS31(11):12. PubMed ID: 1836936
[No Abstract] [Full Text] [Related]
10. Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
Snoeck R; Andrei G; Gérard M; Silverman A; Hedderman A; Balzarini J; Sadzot-Delvaux C; Tricot G; Clumeck N; De Clercq E
Clin Infect Dis; 1994 Apr; 18(4):570-8. PubMed ID: 8038312
[TBL] [Abstract][Full Text] [Related]
11. Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
Bevilacqua F; Marcello A; Toni M; Zavattoni M; Cusini M; Zerboni R; Gerna G; Palù G
J Acquir Immune Defic Syndr (1988); 1991; 4(10):967-9. PubMed ID: 1832460
[TBL] [Abstract][Full Text] [Related]
12. Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
Safrin S; Berger TG; Gilson I; Wolfe PR; Wofsy CB; Mills J; Biron KK
Ann Intern Med; 1991 Jul; 115(1):19-21. PubMed ID: 1646585
[TBL] [Abstract][Full Text] [Related]
13. [Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
Jansen CL; Maris-Tegeler WG; Wertheim-van Dillen PM; Frissen PH; Weiland HT; van der Noordaa J
Ned Tijdschr Geneeskd; 1992 Feb; 136(6):280-4. PubMed ID: 1311058
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of progressive acyclovir-resistant herpes simplex virus using intravenous foscarnet in a patient with the acquired immunodeficiency syndrome.
Sall RK; Kauffman CL; Levy CS
Arch Dermatol; 1989 Nov; 125(11):1548-50. PubMed ID: 2554819
[TBL] [Abstract][Full Text] [Related]
15. Acyclovir-resistant herpes in AIDS treated with foscarnet.
Youle MM; Hawkins DA; Collins P; Shanson DC; Evans R; Oliver N; Lawrence A
Lancet; 1988 Aug; 2(8606):341-2. PubMed ID: 2899762
[No Abstract] [Full Text] [Related]
16. Cutaneous herpes simplex virus infections.
Arbesfeld DM; Thomas I
Am Fam Physician; 1991 May; 43(5):1655-64. PubMed ID: 1826983
[TBL] [Abstract][Full Text] [Related]
17. Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
Birch CJ; Tyssen DP; Tachedjian G; Doherty R; Hayes K; Mijch A; Lucas CR
J Infect Dis; 1992 Jul; 166(1):108-12. PubMed ID: 1318909
[TBL] [Abstract][Full Text] [Related]
18. Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
Pechère M; Wunderli W; Trellu-Toutous L; Harms M; Saura JH; Krischer J
Dermatology; 1998; 197(3):278-80. PubMed ID: 9812037
[TBL] [Abstract][Full Text] [Related]
19. Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
Birch CJ; Tachedjian G; Doherty RR; Hayes K; Gust ID
J Infect Dis; 1990 Sep; 162(3):731-4. PubMed ID: 2167340
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
Alenius S; Berg M; Broberg F; Eklind K; Lindborg B; Oberg B
J Infect Dis; 1982 Apr; 145(4):569-73. PubMed ID: 6279738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
